
Medi Caps Hits 52-Week Low Amid Broader Market Recovery, Raises Financial Concerns
2025-03-27 09:57:58Medi Caps, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today despite a broader market recovery. The company faces significant financial challenges, including operating losses, a poor ability to service debt, and a substantial decline in profitability, raising concerns about its market position.
Read More
Medi Caps Hits 52-Week Low Amid Broader Market Recovery, Signals Financial Struggles
2025-03-27 09:57:57Medi Caps, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, underperforming against a recovering broader market. The company reported significant operating losses and a sharp decline in profitability, raising concerns about its long-term fundamentals and technical trends.
Read More
Medi Caps Hits 52-Week Low Amid Broader Market Recovery and Operational Challenges
2025-03-27 09:57:54Medi Caps, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, underperforming amid a broader market recovery. The company has faced operational challenges, reporting an operating loss and a significant decline in profitability, indicating difficulties in managing its financial obligations.
Read More
Medi Caps Hits 52-Week Low Amid Broader Market Recovery, Raising Financial Concerns
2025-03-27 09:57:49Medi Caps, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low amid a broader market recovery. The company faces financial challenges, including operating losses and a low return on equity, while its profitability has significantly declined, indicating ongoing struggles in a competitive environment.
Read MoreMedi Caps Experiences Technical Trend Shifts Amid Market Volatility and Mixed Outlook
2025-02-25 10:32:30Medi Caps, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 47.51, down from a previous close of 49.46, with a 52-week high of 61.00 and a low of 40.56. Today's trading saw a high of 49.40 and a low of 47.50, indicating some volatility. The technical summary reveals a mixed outlook, with the MACD showing bearish signals on a weekly basis and mildly bearish on a monthly basis. The Bollinger Bands indicate a mildly bearish trend weekly, while monthly signals lean towards a mildly bullish stance. Moving averages also reflect a mildly bearish sentiment on a daily basis. In terms of performance, Medi Caps has shown varied returns compared to the Sensex. Over the past week, the stock returned 7.98%, contrasting with a -1.72% return for the Sensex. However, over longer periods, such a...
Read More
Medi Caps Reports Financial Results Indicating Significant Shift in Performance Metrics
2025-02-12 22:50:44Medi Caps, a microcap company in the Pharmaceuticals & Drugs sector, announced its financial results for the quarter ending December 2024 on February 12, 2025. The report highlights a significant change in the company's financial performance, prompting stakeholders to closely monitor its evolving situation within the industry.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
04-Apr-2025 | Source : BSECertificate for compliance of Regulation 74(5) of SEBI(DP) Regulation 2018 for the quarter ended 31.03.2025
Closure of Trading Window
26-Mar-2025 | Source : BSEThe trading window shall remain closed for trading of shares of the company from 01.04.2025 till completion of 48 hours of declaration of audited financial results for the quarter and financial year end on 31.03.2025
Intimation Under Regulation 30 For Inspection Of U.S. FDA Of Wholly Owned Subsidiary
24-Feb-2025 | Source : BSEIntimation for U.S. FDA inspection of wholly owned subsidiary
Corporate Actions
No Upcoming Board Meetings
Medi Caps Ltd has declared 15% dividend, ex-date: 20 Sep 12
No Splits history available
Medi Caps Ltd has announced 3:1 bonus issue, ex-date: 19 Mar 13
No Rights history available